Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1473832A details a novel catalytic synthesis for d-biotin intermediates, offering superior yield and purity for reliable pharmaceutical supply chains.
Patent CN110642798B reveals a green aqueous synthesis for quinoxalinediones using ammonium persulfate. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN107216326A reveals novel tandem catalysis for phenanthridine derivatives. Enables cost reduction and scalable supply for high-purity pharmaceutical intermediates manufacturing.
Novel thiourea-catalyzed asymmetric synthesis of trifluoromethyl bisoxazoles with high ee. Ideal for anticancer drug development and cost-effective API manufacturing.
Novel Ru/Ni dual-catalyzed method for cyano-enamines offers mild conditions and high selectivity, optimizing pharmaceutical intermediate supply chains.
Patent CN102241614B details a phosphotungstic acid catalyzed method for N-alkyl amides offering significant supply chain stability and cost reduction advantages.
Patent CN106995373B reveals a one-pot synthesis method using ammonium iodide. This breakthrough offers significant supply chain stability and cost reduction advantages.
Patent CN114436912A reveals a cinchona-catalyzed route for carbon-nitrogen axis chiral sulfonamides. Achieves high enantioselectivity and yield under mild conditions for cost-effective manufacturing.
Patent CN103980152B reveals novel benzamide synthesis. Offers cost reduction and supply chain reliability for anti-tumor drug manufacturing.
Patent CN105801336A reveals high-yield phenanthrene synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN107032972B details a catalytic asymmetric Diels-Alder route for flavonoid intermediates, offering high enantioselectivity and simplified purification for pharmaceutical manufacturing.
Patent CN109666030B details a novel spirocyclic amine catalyzed route for codeine and morphine, offering high enantioselectivity and supply chain independence from poppy cultivation.
Novel imidazolium-functionalized ferrocene ligands enable high-yield asymmetric allylic substitution with recyclable catalyst properties for pharmaceutical intermediates.
Novel solvent-free synthesis of indolizine derivatives using Sm(OTf)3 catalyst. Reduces pollution and cost for pharmaceutical intermediates. Reliable supply chain partner.
Advanced patent CN114369031B details high-yield synthesis for polyimide intermediates. Discover cost-effective supply chain solutions and scalable production methods.
Novel pentacyanocyclopentadiene catalyst method for bisphenol AF. Reduces corrosion and enhances purity. Reliable supplier for fluoropolymer intermediates offering cost reduction.
Patent CN117567428A reveals a high-yield synthesis method for bis(2,3-epithiopropyl) sulfide, offering significant supply chain stability and cost reduction for optical resin manufacturing.
Discover the novel two-step synthesis of polysubstituted tetrahydrofuran dienoids from patent CN112142694A. Achieve cost reduction in pharmaceutical intermediate manufacturing with high yields.
Patent CN101041638B reveals novel metal-free chiral amines. Discover cost-effective synthesis and high-purity supply for asymmetric catalysis applications.
Novel electrochemical method replaces gold catalysts for trans-olefin production. High purity, room temperature process offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.